Five Things Facing Teva's New CEO Richard Francis :: Generics Bulletin
DEF 14A
Teva Pharmaceutical Stock Could Double | Barron's
Kare Schultz | C-SPAN.org
Teva Pharmaceuticals - Wikipedia
A Look At Kare Schultz, The New CEO In Charge Of Teva
Teva Shareholders Criticize Generics CEO Switch | CHEManager
Teva Pharmaceuticals will pay $420 million in a federal case
Top Teva exec says company picked N.J. because of its 'value,' history in life sciences | ROI-NJ
Teva Pharmaceuticals - Wikipedia
Troubled Teva appoints new CEO in bid for direction | The Times of Israel
Teva sees higher margins, lower debt from restructuring | Financial Times
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
The U.S. Opioid Abuse Lawsuits Are Political, Says Teva CEO | Ctech
Teva CEO Schultz took a big pay cut last year—but he bagged a contract extension, too | Fierce Pharma
Teva Pharmaceuticals - Wikiwand
Sol Barer elected chairman of Israel's Teva Pharmaceuticals - NJBIZ
Where is Kåre Schultz? | Ctech
Teva completes $40b purchase of Allergan generics arm | The Times of Israel
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva Shares Plunge as CEO Steps Down From Israeli Pharmaceutical Giant – The Forward
Teva Pharmaceuticals Culture | Comparably
Teva timeline: CEO says 20-25 manufacturing plants to close in next two years
New Teva CEO shakes up structure and leadership at troubled drugmaker | The Times of Israel
